Trupanion (NASDAQ:TRUP) Rating Reiterated by Northland Securities

Trupanion (NASDAQ:TRUP)‘s stock had its “buy” rating reaffirmed by Northland Securities in a report issued on Wednesday, AnalystRatings.com reports. They presently have a $40.00 price objective on the financial services provider’s stock. Northland Securities’ price objective points to a potential upside of 27.06% from the company’s previous close.

Other equities research analysts have also issued reports about the stock. TheStreet lowered shares of Trupanion from a “c” rating to a “d+” rating in a research report on Tuesday, July 30th. ValuEngine lowered shares of Trupanion from a “strong-buy” rating to a “buy” rating in a report on Friday, August 16th. BidaskClub lowered shares of Trupanion from a “sell” rating to a “strong sell” rating in a report on Tuesday, October 8th. Craig Hallum set a $20.00 price objective on shares of Trupanion and gave the stock a “hold” rating in a report on Friday, October 11th. Finally, Zacks Investment Research lowered shares of Trupanion from a “hold” rating to a “strong sell” rating in a report on Sunday, November 3rd. Two analysts have rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $36.00.

TRUP stock traded up $1.06 during mid-day trading on Wednesday, hitting $31.48. The company had a trading volume of 311,900 shares, compared to its average volume of 273,807. The firm has a market cap of $836.35 million, a PE ratio of -1,049.33 and a beta of 1.50. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.80 and a current ratio of 1.80. Trupanion has a 12 month low of $20.84 and a 12 month high of $37.13. The stock’s fifty day moving average price is $23.89 and its two-hundred day moving average price is $29.27.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Tuesday, November 5th. The financial services provider reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.04. The business had revenue of $99.28 million for the quarter, compared to analyst estimates of $97.24 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 2.09%. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.03 earnings per share. Equities analysts anticipate that Trupanion will post -0.13 earnings per share for the current year.

In other news, CEO Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $23.92, for a total value of $95,680.00. Following the completion of the sale, the chief executive officer now directly owns 1,462,499 shares in the company, valued at approximately $34,982,976.08. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Over the last 90 days, insiders sold 21,300 shares of company stock valued at $509,446. Company insiders own 13.61% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in TRUP. Aperio Group LLC bought a new stake in shares of Trupanion in the 2nd quarter worth approximately $166,000. US Bancorp DE raised its holdings in Trupanion by 6.0% during the 2nd quarter. US Bancorp DE now owns 6,145 shares of the financial services provider’s stock valued at $222,000 after buying an additional 350 shares during the last quarter. SG Americas Securities LLC bought a new stake in Trupanion during the 2nd quarter valued at $288,000. Global Endowment Management LP bought a new stake in Trupanion during the 2nd quarter valued at $374,000. Finally, Meridian Investment Counsel Inc. raised its holdings in Trupanion by 9.6% during the 2nd quarter. Meridian Investment Counsel Inc. now owns 13,725 shares of the financial services provider’s stock valued at $496,000 after buying an additional 1,200 shares during the last quarter. Hedge funds and other institutional investors own 94.93% of the company’s stock.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

See Also: Front-End Load

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.